Robuta

https://www.wikidata.org/wiki/Q27729793 Mechanism of CDK activation revealed by the structure of a cyclinA-CDK2 complex - Wikidata https://www.ncbi.nlm.nih.gov/Structure/pdb/8ERN 8ERN: Cyclin-free CDK2 in complex with Cpd21 cyclinfreecdk2complex https://pmc.ncbi.nlm.nih.gov/articles/PMC109035/ c-Myc or Cyclin D1 Mimics Estrogen Effects on Cyclin E-Cdk2 Activation and Cell Cycle Reentry - PMC Estrogen-induced progression through G1 phase of the cell cycle is preceded by increased expression of the G1-phase regulatory proteins c-Myc and cyclin D1. To... https://www.rcsb.org/structure/1Y8Y RCSB PDB - 1Y8Y: Crystal structure of human CDK2 complexed with a pyrazolo[1,5-a]pyrimidine... Crystal structure of human CDK2 complexed with a pyrazolo[1,5-a]pyrimidine inhibitor https://www.rcsb.org/structure/3EID RCSB PDB - 3EID: CDK2/CyclinA complexed with a pyrazolopyridazine inhibitor CDK2/CyclinA complexed with a pyrazolopyridazine inhibitor rcsb pdbwith a3eidcdk2inhibitor https://www.wikidata.org/wiki/Q41744166 Contribution of the dual coding capacity of the p16INK4a/MTS1/CDK2 locus to human malignancies -... scientific article published on January 1, 1997 https://www.rcsb.org/structure/6P3W RCSB PDB - 6P3W: Crystal structure of the Cyclin A-CDK2-ORC1 complex Crystal structure of the Cyclin A-CDK2-ORC1 complex rcsb pdbcrystal structureof the https://elifesciences.org/reviewed-preprints/104545 Therapeutic benefits of maintaining CDK4/6 inhibitors and incorporating CDK2 inhibitors beyond... therapeutic benefitsmaintainingcdk4 https://www.ncbi.nlm.nih.gov/Structure/pdb/3QL8 3QL8: CDK2 in complex with inhibitor JWS-6-260 Cyclin-dependent kinase 21,2-ETHANEDIOL3-(4-amino-1,3,5-triazin-2-yl)-4-hydroxybenzonitrile cdk2complexinhibitorjws6 https://www.rcsb.org/structure/3R1Y RCSB PDB - 3R1Y: CDK2 in complex with inhibitor KVR-1-134 CDK2 in complex with inhibitor KVR-1-134 rcsb pdbcdk2 https://www.ncbi.nlm.nih.gov/Structure/pdb/3R7V 3R7V: CDK2 in complex with inhibitor KVR-1-9 Cyclin-dependent kinase 21,2-ETHANEDIOL5-nitro-2-[(pyridin-2-ylmethyl)amino]benzamide cdk2complexinhibitorkvr1 https://www.rcsb.org/structure/3QL8 RCSB PDB - 3QL8: CDK2 in complex with inhibitor JWS-6-260 CDK2 in complex with inhibitor JWS-6-260 rcsb pdbcdk2 https://www.mdanderson.org/newsroom/research-newsroom/study-reveals-synergistic-effect-of-cdk2-and-cdk4-6-combination-.h00-159852189.html Study reveals synergistic effect of CDK2 and CDK4/6 combination therapy | UT MD Anderson A new preclinical study from researchers at The University of Texas MD Anderson Cancer Center, published today in Nature Communications, identifies a powerful... https://pmc.ncbi.nlm.nih.gov/articles/PMC16624/ Nuclear accumulation of cyclin E/Cdk2 triggers a concentration-dependent switch for the destruction... The action of cyclin-dependent kinases (CDKs) is regulated by phosphorylation, cyclin levels, the abundance of CDK inhibitors, and, as recently has been shown... https://www.rcsb.org/structure/1G5S RCSB PDB - 1G5S: CRYSTAL STRUCTURE OF HUMAN CYCLIN DEPENDENT KINASE 2 (CDK2) IN COMPLEX WITH THE... CRYSTAL STRUCTURE OF HUMAN CYCLIN DEPENDENT KINASE 2 (CDK2) IN COMPLEX WITH THE INHIBITOR H717 https://www.ncbi.nlm.nih.gov/Structure/pdb/3QX2 3QX2: CDK2 in complex with inhibitor KVR-1-190 cdk2complexinhibitorkvr1 https://pmc.ncbi.nlm.nih.gov/articles/PMC23327/ Regulation of estrogen receptor transcriptional enhancement by the cyclin A/Cdk2 complex - PMC We have found that ectopic expression of cyclin A increases hormone-dependent and hormone-independent transcriptional activation by the estrogen receptor in... https://www.flightaware.com/live/airport/CDK2 CDK2 Diavik Airport (CDK2) - FlightAware Diavik, Diavik Diamond Mine, Northwest Terrories (CDK2CDK2) flight tracking (arrivals, departures, en route, and scheduled flights) and airport status. diavik airportcdk2flightaware https://www.wikidata.org/wiki/Q47975729 Increased level of p21 in human ovarian tumors is associated with increased expression of cdk2,... scientific article published in June 1998 https://www.ncbi.nlm.nih.gov/Structure/pdb/1YKR 1YKR: Crystal structure of cdk2 with an aminoimidazo pyridine inhibitor crystal structurecdk2pyridineinhibitor https://www.ncbi.nlm.nih.gov/Structure/pdb/2C5X 2C5X: Differential Binding Of Inhibitors To Active And Inactive Cdk2 Provides Insights For Drug... https://elifesciences.org/reviewed-preprints/98357 Fish CDK2 recruits Dtx4 to degrade TBK1 through ubiquitination in the antiviral response https://www.rcsb.org/structure/6Q4B RCSB PDB - 6Q4B: CDK2 in complex with FragLite13 CDK2 in complex with FragLite13 rcsb pdbcdk2complex https://www.ncbi.nlm.nih.gov/Structure/pdb/2JGZ 2JGZ: Crystal structure of phospho-CDK2 in complex with Cyclin B CELL DIVISION PROTEIN KINASE 2G2/MITOTIC-SPECIFIC CYCLIN-B1 crystal structurephospho https://www.rcsb.org/structure/6GUK RCSB PDB - 6GUK: CDK2 in complex with CGP74514A CDK2 in complex with CGP74514A rcsb pdbcdk2complex https://www.rcsb.org/structure/3TIY RCSB PDB - 3TIY: CDK2 in complex with NSC 35676 CDK2 in complex with NSC 35676 rcsb pdbcdk2complexnsc https://www.rcsb.org/structure/1W0X RCSB PDB - 1W0X: Crystal structure of human CDK2 in complex with the inhibitor olomoucine. Crystal structure of human CDK2 in complex with the inhibitor olomoucine. https://www.rcsb.org/structure/1H00 RCSB PDB - 1H00: CDK2 in complex with a disubstituted 4, 6-bis anilino pyrimidine CDK4 inhibitor CDK2 in complex with a disubstituted 4, 6-bis anilino pyrimidine CDK4 inhibitor https://pmc.ncbi.nlm.nih.gov/articles/PMC12256406/ Identification of CDK2 as a key apoptotic gene for predicting cervical cancer prognosis using... Objectives: This study aimed to identify apoptosis - related genes with diagnostic and prognostic value in cervical cancer (CC) using integrated bioinformatics... https://www.ncbi.nlm.nih.gov/Structure/pdb/7M2F 7M2F: CDK2 with compound 14 inhibitor with carboxylate cdk2compound14inhibitorcarboxylate https://www.rcsb.org/structure/3RAL RCSB PDB - 3RAL: CDK2 in complex with inhibitor RC-2-34 CDK2 in complex with inhibitor RC-2-34 rcsb pdbcdk2 https://www.ncbi.nlm.nih.gov/Structure/pdb/3R73 3R73: CDK2 in complex with inhibitor KVR-1-164 Cyclin-dependent kinase 21,2-ETHANEDIOL4-[(3-aminopropyl)amino]-5-nitro-2-[(pyridin-3-ylmethyl)amino]benzamide cdk2complexinhibitorkvr1 https://www.rcsb.org/structure/1JVP RCSB PDB - 1JVP: Crystal structure of human CDK2 (unphosphorylated) in complex with PKF049-365 Crystal structure of human CDK2 (unphosphorylated) in complex with PKF049-365 https://www.ncbi.nlm.nih.gov/Structure/pdb/5ANG 5ANG: Crystal structure of CDK2 in complex with 7-hydroxy-4-(morpholinomethyl)chromen-2-one... CYCLIN-DEPENDENT KINASE 27-HYDROXY-4-(MORPHOLINOMETHYL)CHROMEN-2-ONE https://www.rcsb.org/structure/6GUE RCSB PDB - 6GUE: CDK2/CyclinA in complex with AZD5438 CDK2/CyclinA in complex with AZD5438 rcsb pdbcdk2complex https://www.rcsb.org/structure/2IW9 RCSB PDB - 2IW9: STRUCTURE OF HUMAN THR160-PHOSPHO CDK2-CYCLIN A COMPLEXED WITH A... STRUCTURE OF HUMAN THR160-PHOSPHO CDK2-CYCLIN A COMPLEXED WITH A BISANILINOPYRIMIDINE INHIBITOR https://www.rcsb.org/structure/2C6M RCSB PDB - 2C6M: Crystal structure of the human CDK2 complexed with the triazolopyrimidine inhibitor Crystal structure of the human CDK2 complexed with the triazolopyrimidine inhibitor https://finviz.com/news/343413/kymera-therapeutics-announces-gilead-sciences-option-exercise-to-license-kt-200-oral-cdk2-molecular-glue-degrader-development-candidate Kymera Therapeutics Announces Gilead Sciences' Option Exercise to License KT-200, Oral CDK2... Stock screener for investors and traders, financial visualizations. https://www.rcsb.org/structure/1KE6 RCSB PDB - 1KE6: CYCLIN-DEPENDENT KINASE 2 (CDK2) COMPLEXED WITH... cyclin dependent kinase 2rcsb pdbcdk2 https://www.rcsb.org/structure/3SW4 RCSB PDB - 3SW4: Crystal Structure of the CDK2 in complex with thiazolylpyrimidine inhibitor Crystal Structure of the CDK2 in complex with thiazolylpyrimidine inhibitor